Lexicon Pharmaceuticals Product Pipeline Review 2012


Naperville, IL -- (SBWIRE) -- 07/02/2012 -- Lexicon Pharmaceuticals Product Pipeline Review 2012 provides data on the Lexicon Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- Lexicon Pharmaceuticals, Inc. - Brief Lexicon Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Lexicon Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Lexicon Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Lexicon Pharmaceuticals, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Lexicon Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Lexicon Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Lexicon Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Lexicon Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Lexicon Pharmaceuticals, Inc. and identify potential opportunities in those areas.


Current R&D Portfolio of Lexicon Pharmaceuticals, Inc.; Lexicon Pharmaceuticals, Inc. - Key Therapeutics; Lexicon Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Lexicon Pharmaceuticals, Inc. - News; Lexicon Pharmaceuticals, Inc. - Latest Updates; Lexicon Pharmaceuticals, Inc. - Pipeline; Lexicon Pharmaceuticals, Inc. - Discontinued/Dormant Projects

To view the detailed table of contents for this report please visit: